154 related articles for article (PubMed ID: 3106693)
1. Rearrangement of the c-myc oncogene with heavy-chain immunoglobulin enhancer in tumor DNA from an acute lymphoblastic leukemia patient.
Guerrasio A; Avanzi GC; Pegoraro L; Estivill X; Serra A; Giubellino MC; Fierro MT; Novarino A; Foa R; Saglio G
J Natl Cancer Inst; 1987 May; 78(5):845-51. PubMed ID: 3106693
[TBL] [Abstract][Full Text] [Related]
2. [Rearrangement of the proto-oncogene c-myc in fresh cells from Burkitt's leukemia (L3)].
Mathieu-Mahul D; Bernheim A; Berger R; Mauchauffe M; Flandrin G; Larsen CJ
Nouv Rev Fr Hematol (1978); 1985; 27(3):157-61. PubMed ID: 2993997
[TBL] [Abstract][Full Text] [Related]
3. Pre-B-cell leukemia with a t(8; 14) and a t(14; 18) translocation is preceded by follicular lymphoma.
Gauwerky CE; Hoxie J; Nowell PC; Croce CM
Oncogene; 1988 May; 2(5):431-5. PubMed ID: 3131717
[TBL] [Abstract][Full Text] [Related]
4. Antiimmunoglobulin inhibition of Burkitt's lymphoma cell proliferation and concurrent reduction of c-myc and mu heavy chain gene expression.
Arasi VE; Lieberman R; Sandlund J; Kiwanuka J; Novikovs L; Kirsch I; Hollis G; Magrath IT
Cancer Res; 1989 Jun; 49(12):3235-41. PubMed ID: 2497974
[TBL] [Abstract][Full Text] [Related]
5. The t(8; 14) chromosomal translocation occurring in B-cell malignancies results from mistakes in V-D-J joining.
Haluska FG; Finver S; Tsujimoto Y; Croce CM
Nature; 1986 Nov 13-19; 324(6093):158-61. PubMed ID: 3097550
[TBL] [Abstract][Full Text] [Related]
6. B-cell tumorigenesis in mice carrying a yeast artificial chromosome-based immunoglobulin heavy/c-myc translocus is independent of the heavy chain intron enhancer (Emu).
Palomo C; Zou X; Nicholson IC; Bützler C; Brüggemann M
Cancer Res; 1999 Nov; 59(21):5625-8. PubMed ID: 10554044
[TBL] [Abstract][Full Text] [Related]
7. Absence of a paused transcription complex from the c-myc P2 promoter of the translocation chromosome in Burkitt's lymphoma cells: implication for the c-myc P1/P2 promoter shift.
Strobl LJ; Kohlhuber F; Mautner J; Polack A; Eick D
Oncogene; 1993 Jun; 8(6):1437-47. PubMed ID: 8502472
[TBL] [Abstract][Full Text] [Related]
8. Concurrent activation of c-myc and inactivation of bcl-2 by chromosomal translocation in a lymphoblastic lymphoma cell line.
Kiem HP; Nourse J; Saltman DL; Blume KG; Cleary ML
Oncogene; 1990 Dec; 5(12):1815-9. PubMed ID: 2284100
[TBL] [Abstract][Full Text] [Related]
9. [Rearrangement of the c-myc proto-oncogene locus in a cell line of T-lymphoblastic origin].
Caubet JF; Mathieu-Mahul D; Bernheim A; Larsen CJ; Berger R
C R Acad Sci III; 1985; 300(5):171-6. PubMed ID: 3919889
[TBL] [Abstract][Full Text] [Related]
10. Different stages of B cell differentiation in non-T acute lymphoblastic leukemia.
Foa R; Migone N; Saitta M; Fierro MT; Giubellino MC; Lusso P; Cordero di Montezemolo L; Miniero R; Lauria F
J Clin Invest; 1984 Nov; 74(5):1756-63. PubMed ID: 6438157
[TBL] [Abstract][Full Text] [Related]
11. Combined polymerase chain reaction methods to detect c-myc/IgH rearrangement in childhood Burkitt's lymphoma for minimal residual disease analysis.
Busch K; Borkhardt A; Wössmann W; Reiter A; Harbott J
Haematologica; 2004 Jul; 89(7):818-25. PubMed ID: 15257933
[TBL] [Abstract][Full Text] [Related]
12. DNA rearrangements of immunoglobulin genes correlate with phenotypic markers in B-cell malignancies.
Foroni L; Catovsky D; Rabbitts TH; Luzzatto L
Mol Biol Med; 1984 Feb; 2(1):63-79. PubMed ID: 6439975
[TBL] [Abstract][Full Text] [Related]
13. Rapid induction of B-cell lymphomas in mice carrying a human IgH/c-mycYAC.
Bützler C; Zou X; Popov AV; Brüggemann M
Oncogene; 1997 Mar; 14(11):1383-8. PubMed ID: 9178899
[TBL] [Abstract][Full Text] [Related]
14. Level of MYC overexpression in pediatric Burkitt's lymphoma is strongly dependent on genomic breakpoint location within the MYC locus.
Wilda M; Busch K; Klose I; Keller T; Woessmann W; Kreuder J; Harbott J; Borkhardt A
Genes Chromosomes Cancer; 2004 Oct; 41(2):178-82. PubMed ID: 15287031
[TBL] [Abstract][Full Text] [Related]
15. Novel three-break rearrangement and cryptic translocations leading to colocalization of MYC and IGH signals in B-cell acute lymphoblastic leukemia.
Tchinda J; Volpert S; Berdel WE; Büchner T; Horst J
Cancer Genet Cytogenet; 2006 Mar; 165(2):180-4. PubMed ID: 16527615
[TBL] [Abstract][Full Text] [Related]
16. Theophylline induced differentiation provides direct evidence for the deregulation of c-myc in Burkitt's lymphoma and suggests participation of immunoglobulin enhancer sequences.
Sandlund JT; Neckers LM; Schneller HE; Woodruff LS; Magrath IT
Cancer Res; 1993 Jan; 53(1):127-32. PubMed ID: 8416737
[TBL] [Abstract][Full Text] [Related]
17. Activation of the c-myc p1 promoter in Burkitt's lymphoma by the hs3 immunoglobulin heavy-chain gene enhancer.
Hu HM; Kanda K; Zhang L; Boxer LM
Leukemia; 2007 Apr; 21(4):747-53. PubMed ID: 17287852
[TBL] [Abstract][Full Text] [Related]
18. Deregulation of the proto-oncogene c-myc through t(8;22) translocation in Burkitt's lymphoma.
Gerbitz A; Mautner J; Geltinger C; Hörtnagel K; Christoph B; Asenbauer H; Klobeck G; Polack A; Bornkamm GW
Oncogene; 1999 Mar; 18(9):1745-53. PubMed ID: 10208435
[TBL] [Abstract][Full Text] [Related]
19. Variable IgH chain enhancer activity in Burkitt's lymphomas suggests an additional, direct mechanism of c-myc deregulation.
Jain VK; Judde JG; Max EE; Magrath IT
J Immunol; 1993 Jun; 150(12):5418-28. PubMed ID: 8515068
[TBL] [Abstract][Full Text] [Related]
20. Immunoglobulin mu-chain gene rearrangement in a patient with T cell acute lymphoblastic leukemia.
Ha K; Minden M; Hozumi N; Gelfand EW
J Clin Invest; 1984 Apr; 73(4):1232-6. PubMed ID: 6423668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
